CHICAGO, April 18, 2016 /PRNewswire-USNewswire/ -- A Chicago law firm stated today that it is investigating the filing of lawsuits nationwide against AstraZeneca, the makers of Prilosec and Nexium. Moll Law Group has been contacted and is currently investigating claims of chronic kidney disease, acute kidney injury, acute interstitial nephritis, renal failure, kidney failure, and heart attack. Nexium and Prilosec are Proton Pump Inhibitors (PPIs) that are used to decrease the amount of acid produced in the stomach.
Proton Pump Inhibitors are commonly used to treat gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). Prilosec, originally approved as Losec in 1988, was the first member of the Proton Pump Inhibitor class of medications. Nexium is a second generation Proton Pump Inhibitor said to be an improvement on Prilosec. Both are manufactured by AstraZeneca.
A February, 2016 issue of the Journal of the American Medical Association (JAMA), published the results of a new study which showed a higher risk of chronic kidney disease in patients using Proton Pump Inhibitors like Nexium (esomeprazole), Prilosec (omeprazole), and similar prescription and over-the-counter medications. The results showed the risk of chronic kidney disease was higher with prolonged use.
One of the current claims Moll Law Group is reviewing involves a Tennessee man who was prescribed both Prilosec and Nexium. During his use of Prilosec and Nexium, he developed kidney failure, interstitial nephritis, renal failure, and suffered from a heart attack.
Moll Law Group is assisting victims that sustained injuries as a result of using Proton Pump Inhibitors such as Prilosec and Nexium. "We are, at the very least, reviewing the facts of victims' claims and informing them of their options moving forward," stated Attorney Ken Moll, President of Moll Law Group.
About Moll Law Group
Moll Law Group is a national injury law firm based in Chicago helping injured victims obtain the compensation they deserve.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/chicago-law-firm-investigating-the-filing-of-lawsuits-nationwide-against-astrazeneca-the-maker-of-nexium-and-prilosec-for-chronic-kidney-disease-and-heart-attack-injuries-300252558.html
SOURCE Moll Law Group